We verwelkomen je graag
op woensdag 16 november 2022 van 12:50 tot 13:20 voor een symposium over
Oral contraception with estetrol and drospirenone: what is known today?
Met als gastspreker: Dr. G. Grandi (Italy)
The specific characteristics of the new estrogen estetrol will be discussed in addition to the most important clinical data of the EMA approved new combined oral contraceptive containing 14.2mg estetrol and 3 mg drospirenone. Finally some real-world clinical experiences will be shared by Dr. G. Grandi (Italy).
Sessie met de steun van Gedeon Richter Benelux
